No abstract available
Keywords:
Conversion therapy; Hepatocellular carcinoma; Overall survival; Prognostic model; Progression-free survival.
MeSH terms
-
Carcinoma, Hepatocellular* / drug therapy
-
Carcinoma, Hepatocellular* / therapy
-
Chemoembolization, Therapeutic* / methods
-
Humans
-
Immune Checkpoint Inhibitors / therapeutic use
-
Liver Neoplasms* / drug therapy
-
Liver Neoplasms* / pathology
-
Liver Neoplasms* / therapy
-
Phenylurea Compounds* / therapeutic use
-
Prognosis
-
Quinolines* / therapeutic use
Substances
-
lenvatinib
-
Phenylurea Compounds
-
Quinolines
-
Immune Checkpoint Inhibitors